MaaT Pharma SA (EPA:MAAT)
France
· Delayed Price · Currency is EUR 5.34
-0.12 (-2.20%)
May 12, 2025, 5:35 PM CET
MaaT Pharma Revenue
In the year 2024, MaaT Pharma had annual revenue of 3.22M EUR with 44.34% growth. MaaT Pharma had revenue of 1.50M in the half year ending December 31, 2024, with 59.72% growth.
Revenue
3.22M
Revenue Growth
+44.34%
P/S Ratio
26.71
Revenue / Employee
51.05K
Employees
67
Market Cap
85.89M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.17B |
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |